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INTRODUCTION
 Iron essentially a trace element; also possess 
properties of transition during mostbiological 
processes. Body iron is sourced from duodenal 
absorption, specifically in the heme form (Fe+2) and 
is released from both macrophages and liver.1 South 
Asian diet up to 90-95% comprises of non-heme iron 
of total daily iron requirement which is rather poorly 
absorbed by the gut.2 Researchers have shown that 
body iron is known to have a negative association 
withbody mass index (BMI).3,4 Increased plasma 
volume and more significantly, inflammation 
induced by increased adiposity is suggested to 
be a link between iron status and adiposity.5 The 
C- reactive protein (CRP) is the first cytokine to 
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Hyperferritinemia Irrespective of Body Iron Stores
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ABSTRACT
Objective: Obesity causes subclinical inflammation which results in the secretion of various bioactive 
peptides that are key players in metabolic regulation of iron homeostasis. We sought to establish correlation 
of one such peptide (ferritin) with marker of subclinical inflammation (CRP) in various BMI.
Methods: Total 150 subjects between the ages of 20-60 years were included in the cross-sectional study 
conducted at Basic Medical Sciences Institute, Jinnah Post Graduate Medical Centre, Karachi, Pakistan. 
Body Mass Index (BMI) was calculated by weight (kg) /height (m2). The given values were used as reference 
for Group A: normal weight (18.0-22.9 kg/m2), Group B: overweight (23.0-24.9 kg/m2), Group C: obese 
(>25.0 kg/m2) according to South Asian criteria. Serum Iron, Total Iron Binding Capacity, serum Transferrin 
Saturation, serum Ferritin and C-reactive protein were measured by commercially available kits. ANNOVA 
with Tukey’s minimum significant difference and Spearman Rho correlation were used considering p<0.05 
significant.
Results: The results identified an increased serum Ferritin and CRP in obese versus lean subjects (p < 
0.001).  BMI showed significantly positive correlation with serum CRP (r = 0.815; p-value < 0.01) and 
Ferritin (r = 0.584; p-value < 0.01). However, serum Iron levels and Transferrin saturation decreased in 
obese versus normal weight individuals (p < 0.001).
Conclusion: This integrated new data reveals that individuals with high BMI had high levels of Serum 
Ferritin despite low levels of iron with high levels of C- reactive protein.This might be caused due to 
inflammatory conditions prevailing in the presence of increased adipose tissue.
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be elevated in inflammatory conditions such as 
obesity. A strong relationship between obesity 
and CRP has been observed in all populations. 
This is because of the inflammatory changes in 
obese individuals. Concentration of CRP in serum 
decreases significantly after massive weight 
reduction.6 The pathophysiological mechanisms 
linking obesity toelevated levels of CRP are well 
recognized in obesity, the accumulation of free 
fatty acid intermediates activates pro-inflammatory 
serine kinase cascades.7
 Among the many metabolic effects of obesity, 
higher BMI is also correlated with incongruity in 
iron parameters8 as this finding is attributed more 
to being physiological rather than due to dietary 
deficiency.9 Adipose tissue, the endocrine organ 
contributes to the development of inflammation 
process by secreting various pro-inflammatory 
cytokines and adipokines i.e. IL-6, TNF-α, leptin, C- 
reactive protein etc. Certain cytokines/ chemokines 
influence food intake through direct effect of 
hypothalamus (Kershaw and Flier, 2004; Arslanet al., 
2010). According to Zimmermann and Kohrle,10 
chronic inflammation due to obesity results in low 
iron status. An inverse relationship has been found 
between physical activity and weight gain, and it 
has been suggested that physical inactivity could 
be another factor associated with decreased body 
iron in obesity in adults.11 It seems that increased 
body adipose tissue, particularly visceral depots, 
is associated with increased risk of iron deficiency 
which may be masked by high serum ferritin levels, 
presumably because the increase cytokines result in 
increased acute phase reactants synthesis resulting 
in increased macrophage sequestration and/or 
decreased intestinal iron absorption.12,13
 Transferrin saturation and serum ferritin arethe 
preferential indicators for estimation of iron status.14 
Ferritin expression is stimulated by several factors, 
such ascytokinereleased during inflammation and 
liver diseases. Inflammation in turn induces hepatic 
synthesis of acute phaseproteins. Obesity is one 
of the most common and prevalentconditionsthat 
promote this low grade inflammatory environment 
within the body.15
 A relationship between iron status and 
inflammation utilizes C-reactive protein as 
an indicator of inflammation.16 Serum CRP 
concentration is utilized to support and authenticate 
the relationship between high ferritin levels in 
obesity with persistent low iron levels.17 However, 
no study has been carried out in South Asia up 
till now which establishes relationship between 
iron profile with South Asian BMI criteria.18,19 
Keeping this in view, this proposed study aimed to 
elucidate whether obesity associated hypoferemia 
is correctly judged by serum levels of ferritin 
in obese individuals of South Asian and if it is 
correlated with subclinical inflammation.Thus 
we sought to estimate and correlate between 
low grade inflammatory marker (CRP) and iron 
marker (ferritin) in individuals with different BMI 
categories.
METHODS
 This cross-sectional study was conducted in 
Basic Medical Sciences Institute (BMSI), Jinnah 
Postgraduate Medical Centre, Karachi, Pakistan. 
The study was approved by the institutional ethical 
review board. Informed written consent was 
obtained from all study participants.
 Total 380 healthy individuals between the 
ages of 20-60 years irrespective of gender were 
interviewed in detail regarding their medical, 
surgical and personal history to validate/confirm 
their suitability for inclusion in this study. Two 
hundred thirty individuals were excluded on 
the basis of conditions which influence the 
body iron stores such as pregnancy, alcoholism, 
hemoglobinopathies, diabetes mellitus, bleeding 
disorders, any acute illness during last one month, 
as well as iron deficiency  as seen on complete blood 
picture (CP). Finally, 150 subjects were included in 
the present study. The subjects were divided into 
three groups with 50 individuals in each. Group 
A: normal weight (18.0-22.9 kg/m2), Group B: 
overweight (23.0-24.9 kg/m2), Group C: obese 
(>25.0 kg/m2) according to South Asian criteria of 
BMI.20,21
 The weight and height of all the subjects were 
measured in kilograms and meters respectively, 
using a weight scale with a built-in Stadiometer (ZT 
-120 Health Scale, Nanjing EverichChina). Subjects 
were asked to stand in an erect posture wearing 
light clothing. Hip and waist circumference was 
measured by standard techniques.22 BMI was 
calculated using the following formula: (weight in 
kg / height in m2).23
 About 6ml of blood was collected using all 
aseptic measures into EDTA vaccutainer (2 ml) 
and serum separator SSTs (4 ml). SST’s were 
centrifuged after complete clotting at 2000xG for 
10 minutes. Clear serum was separated and stored 
in eppendorf at -80ºC until assayed. Hemoglobin 
(gm/dl) was measured on Sysmex (21 Cat No. KX21 
manufactured by Kobe, Japan). Serum iron (mg/
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dl) and TIBC (mg/dl) were analyzed by enzymatic 
colorimetric method (kit Cat. No.61075 and kit 
Ref 61631 supplied by Bio Merieux S.A., France). 
Serum Ferritin (ŋg/dl) and CRP (mg/dl) were 
determined by Enzyme Linked Immuno-Sorbent 
Assay kit method (Cat No. BC- 1025 provided by 
BioCheck and Cat No. KAPDB 4360, manufactured 
by DIA Source, Immuno Assay S.A., Belgium), 
while transferrin saturation was calculated as 100x 
serum iron /TIBC.24
Statistical Analysis: Data was analyzed using 
SPSS- version 19 (version 19; SPSS Inc., Chicago, IL, 
USA). Mean ± SD were calculated for quantitative 
variables. ANNOVA with Tukey’s minimum 
significant difference was used as a post hoc test, 
assuming homogeneity of variances. Spearman Rho 
correlation was applied to measure the relationship 
of obesity (as depicted by BMI) with ferritin, TIBC, 
iron and CRP and significance was considered at 
the level of p<0.05.
RESULTS
 The mean biophysical parameters of all three 
groups are shown in (Table-I). Mean weight 
was found significantly different between 
Group C when compared to Group A (p<0.001). 
The meanwaist and hip circumference among 
the three groups were also significantly different 
(p-value < 0.001),whereas no significant difference 
was observed in the waist to hip ratios among all 
three groups (p = 0.387). BMI in all three groups 
was significantly different (p<0.001).
Iron status in varying degrees of adiposity
Fig.1: (A-D):Hemoglobin and iron parameters among all groups. Box plot shows the mean, 25th and 75th quartiles for 
Ferritin (a), Iron (b), TIBC (c) & Transferrin saturation (d)in three groups. X axis shows the study groups of normal 
weight (n= 50), overweight (n= 50) and obese (n= 50). Y axis shows the BMI obtained. Annovaposthoc test was applied 
for significant difference between Control vs. Overweight, Control vs. Obese and Overweight vs. Obese. P value<0.05 is 
considered significant.
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 The biochemical parameters are illustrated 
in (Table-II and Fig.1 A-D). No difference was 
observed in the meanhemoglobin values in all three 
groups. Serum ferritin levelswere high while serum 
iron were low in group Csubjects as compared 
to groups A and B (p < 0.001): TIBC was found 
to be significantly lower in group B (p < 0.001) as 
compared to group Awhile significantly higher 
in group Cas compared to  group B (p < 0.001). 
Transferrin saturation percentage was high in group 
B as compared to group A (p = 0.001), and decreased 
in group Cas compared to the group A and group B 
(p < 0.001).The serum CRP levels depicted a rising 
trend from group A to C and showed significantly 
positive correlation with BMI (r = 0.815; p-value < 
0.01) and Ferritin (r = 0.584; p-value < 0.01). Ferritin 
showed a positive correlation with increasing BMI 
(r = 0.614; p-value < 0.01) while negative correlation 
were observed for iron (r = -0.476; p-value < 0.01)
and transferrin saturation percentage (r = -0.419; 
p-value < 0.01).(Table-III)
DISCUSSION
 Obesity accounts for iron deficiency with or 
without anemia. This could be attributed to certain 
mechanisms associated to the pathogenesis of 
obesity, such as low grade inflammation.25 The 
trend noticed in this study was an increase in 
TIBC in overweight individualswhen compared to 
normal weight, while iron concentration decreased.
However, in obese individuals the TIBC levels tend 
to maintain near the normal values with persistent 
decreased iron levels (Table-II). These findings 
are contradictoryto what has been reported by 
Ghadiriet al,26 who described no change in TIBC 
with increase in BMI.
 Studies have previously revealed lower levels 
of iron and transferrin saturation in obese as 
Faiza Alam et al.
Table-I: Biophysical and anthropometric 
variables among all groups.
Variables Group A Group B Group C
 Control Overweight Obese
 (n=50) (n=50) (n=50)
 Mean ±SD Mean ±SD Mean ±SD
Age (years) 30.54±8.63 35.52±6.00 34.24±7.38
Weight (kg) 63.53±24.50 68.28±6.66 77.90±11.49*
Height (cm) 165.9± 8.53 168±7.84 163.18±9.19
Body Mass 21.37±1.53 24.22±0.61* 29.29±4.1#
  Index (kg/m2)
Waist 82.99±7.77 89.32±7.24* 97.12±10.45#
  Circumference (cm)
Hip 94.18±7.84 102.52±7.99* 107.72±11.01#
  Circumference (cm)
Waist Hip 0.87 ±0.16 0.87 ±0.1 0.90 ±0.09
  Ratio (W/H)
* significant as compared to controls, p<0.01
^ significant as compared to overweight, p<0.01
# significant as compared to controls and overweight 
p<0.01
Table-III: Correlation of BMI with 
various study parameters.
Parameters  Spearman Rho P value
 correlation (r)
Hemoglobin (g/dl) 0.080 0.18
Ferritin (ŋg/dl) 0.614 <0.01
Iron(mg/dl) -0.476 <0.01
Total Iron Binding -0.038 0.25
  Capacity (mg/dl)
Transferrin Saturation -0.419 <0.01
  (Trans Sat%)
CRP(mg/dl) 0.815 <0.01
Correlation of Feritin with:
CRP 0.584 <0.01
Significant Correlation p<0.01, 
Where CRP: C- Reactive Protein;BMI: Body Mass Index.
Table-II: Biochemical variables among all groups.
Variables Group A Group B Group C 
 Normal weight Overweight Obese
 (n=50) (n=50) (n=50)
 Mean ±SD Mean ±SD Mean ±SD
Hemoglobin (gm/dl) 13.04±2.68 12.7 ±1.66 13.62±1.77
Serum Ferritin (ŋg/dl) 31.62±13.23 34.23±12.45 136.15±59.3#
Serum Iron (mg/dl) 1.96±0.85 2.06±0.59 0.85±0.39#
Total Iron Binding Capacity (µg/dl) 3.46±0.61 2.84±0.61* 3.34±0.61^
Transferrin Saturation (trans sat%) 57.98±25.71 73.69 ±18.52* 26.63±13.90#
C- Reactive Protein (mg/dl) 2.22 ±1.11 3.83 ±1.12* 8.33 ±2.66#
* significant as compared to controls, p<0.01
^ significant as compared to overweight, p<0.01
# significant as compared to controls and overweight p<0.01
compared to the normal weight individuals and a 
negative correlation of transferrin saturation with 
BMI.25-27 Current study also supports this trend, 
suggesting that low iron levels could be a result of 
increased body iron demand, dilutional effect of 
increased plasma volume and most importantly, 
sequestration of iron through inflammatory-
mediated mechanisms. Despite low iron levels no 
variations in hemoglobin levels was observed in 
study subjects. This observation could be related to 
the study’s exclusion criteria.
 The surprising finding in this study was the 
elevated ferritin levels observed in the obese group 
along with a positive correlation with BMI. Various 
studiesconducted on obese metabolic syndrome 
patients versus obese non-metabolic syndrome 
patients reported higher levels and positive 
correlation of ferrit in with BMI between the groups, 
arguing against the presence of iron overload and 
advocating some level of inflammation responsible 
for high levels of ferritin (Table-II and Fig.1).28,29 In a 
recent study conducted by our group, we found 
elevated levels of serum ferritin, insulin, HOMA-IR 
and hs-CRP with low serum iron levels in Type II 
diabetics. We proposed that ferritin in combination 
with CRP may cause an undesirable inflammatory 
environment leading to insulin resistance.30
 A study by Eftekhariet al.31 has demonstrated 
serum ferritin levels to be decreased in obesity. 
These discrepancies might be due to urbanization 
and lack of physical activity accompanied with junk 
food having less iron density. CRP is considered 
to be one of the earliest markers detected in 
inflammatory conditions. The study yielded high 
serum CRP levels in obese individuals.Our results 
suggest that obesity may cause activation of certain 
inflammatory mechanisms and increased cytokine 
secretion from adipose tissue, which in turn 
increases the hepatic secretion of CRP.6,32 In the obese 
group, with increasing BMI, iron concentration 
and transferrin saturation falls with ferritin and 
CRP concentration risefour folds. Thedecreased 
ironlevels in obese individualsmight be potentiated 
by the inflammatory mechanisms, which entraps 
iron in the reticulo-endothelial system and activates 
the secretion of certain cytokines.Simultaneous 
increase in ferritin and CRPlevels in the presence of 
excessive fat content of the body may induceferritin 
to act as an acute phase reactant.
Limitation of the study:The limitation of this 
study is its cross-sectional design. Comparative 
large population scale studies are not available to 
determine the baseline values of the iron parameters 
in our population.However, this study proposes a 
causal relationship between obesity, inflammation 
and low iron levels.
CONCLUSION
 Obese individuals show a unique picture of high 
ferritin and C- reactive protein, low serum iron and 
transferrin saturation. This may be an indication 
of fat cells playing a vital role in the production of 
acute phase reactants like ferritin which may not be 
the gold standard for the evaluation of iron status in 
obese individuals. 
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